Literature DB >> 18692565

Human embryonic stem cells as a model system for studying the effects of smoke exposure on the embryo.

Tamara Zdravkovic1, Olga Genbacev, Nicholas LaRocque, Michael McMaster, Susan Fisher.   

Abstract

Human embryonic stem cells (hESCs) share many characteristics including pluripotency with cells of the early embryo and so are potentially useful tools for studying the harmful effects of xenobiotics during early development. Here, we used hESCs as a model system to test the effects of nicotine on the pluripotent population of cells that forms the whole body. Specifically, we exposed hESCs (H7 and H9) to various concentrations of nicotine ranging from 0.1 to 6microM. We evaluated the effects in terms of cell adhesion, integrin expression, hESC colony morphology, markers of pluripotency and survival. The results revealed a significant negative impact of nicotine in the dose range between 1.8 and 3.7microM on all the endpoints analyzed. The observed effects were reversed by the addition of the nicotine antagonist d-tubocurarine, suggesting that the effects are receptor mediated. Together these results offer new explanations in terms of embryo toxicity for the large negative impact of cigarette smoke exposure on a woman's reproductive capacity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692565     DOI: 10.1016/j.reprotox.2008.07.004

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  9 in total

1.  Diverse neurotoxicants target the differentiation of embryonic neural stem cells into neuronal and glial phenotypes.

Authors:  Theodore A Slotkin; Samantha Skavicus; Jennifer Card; Edward D Levin; Frederic J Seidler
Journal:  Toxicology       Date:  2016-11-02       Impact factor: 4.221

2.  Developmental effects of tobacco smoke exposure during human embryonic stem cell differentiation are mediated through the transforming growth factor-β superfamily member, Nodal.

Authors:  Walter Liszewski; Carissa Ritner; Julian Aurigui; Sharon S Y Wong; Naveed Hussain; Winfried Krueger; Cheryl Oncken; Harold S Bernstein
Journal:  Differentiation       Date:  2012-02-28       Impact factor: 3.880

Review 3.  Present state and future perspectives of using pluripotent stem cells in toxicology research.

Authors:  Anna M Wobus; Peter Löser
Journal:  Arch Toxicol       Date:  2011-01-12       Impact factor: 5.153

4.  Comparison of the toxicity of smoke from conventional and harm reduction cigarettes using human embryonic stem cells.

Authors:  Sabrina Lin; Shawn Fonteno; Jo-Hao Weng; Prue Talbot
Journal:  Toxicol Sci       Date:  2010-08-11       Impact factor: 4.849

5.  The effect of nicotine on the mechanical properties of mesenchymal stem cells.

Authors:  Juan P Ruiz; Daniel Pelaez; Janice Dias; Noël M Ziebarth; Herman S Cheung
Journal:  Cell Health Cytoskelet       Date:  2012-03-28

6.  Cardiac development in zebrafish and human embryonic stem cells is inhibited by exposure to tobacco cigarettes and e-cigarettes.

Authors:  Nathan J Palpant; Peter Hofsteen; Lil Pabon; Hans Reinecke; Charles E Murry
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

7.  Single-Cell RNA Sequencing of Human Embryonic Stem Cell Differentiation Delineates Adverse Effects of Nicotine on Embryonic Development.

Authors:  Hongchao Guo; Lei Tian; Joe Z Zhang; Tomoya Kitani; David T Paik; Won Hee Lee; Joseph C Wu
Journal:  Stem Cell Reports       Date:  2019-02-28       Impact factor: 7.765

8.  Nicotine exposure during differentiation causes inhibition of N-myc expression.

Authors:  Ahmi Ben-Yehudah; Becki M Campanaro; Laura M Wakefield; Tia N Kinney; Jill Brekosky; Vonya M Eisinger; Carlos A Castro; Diane L Carlisle
Journal:  Respir Res       Date:  2013-11-05

9.  Bidirectional Regulation of Mouse Embryonic Stem Cell Proliferation by Nicotine Is Mediated Through Wnt Signaling Pathway.

Authors:  Qinglan Qu; Fengrong Zhang; Xiang Zhang; Weihong Yin
Journal:  Dose Response       Date:  2017-11-19       Impact factor: 2.658

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.